Knowledge Center

Membership Resources


Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.

After making your filter selections, please scroll down to see results.

Filters
Clear All
Results 388
Articles

Managing the Statin-Intolerant Patient: Low-Dose/Low-Frequency Treatment Regimens

Statin clinical trials suggest an incidence of adverse muscular events of ~ 1.5 – 3%, but the true incidence of statin intolerance (SI) is likely…

Read More |
Articles

Understanding Statin use in America and Gaps in Education – USAGE Survey

Statins play a critical role in reducing the risk of heart disease. Not only are the benefits greatly appreciated by both physicians and patients, the…

Read More |
Articles

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Read More |
Articles

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Read More |
Articles

The importance of non–HDL cholesterol reporting in lipid management

The importance of non–HDL cholesterol reporting in lipid management

Read More |
Articles

NLA Endorses Newly Published 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Jacksonville, Florida – (August 25, 2022) – The American College of Cardiology (ACC) announced the release of the 2022 ACC Expert Consensus Decision Pathway on…

Read More
Articles

Amgen Makes Repatha® Available Through AmgenNow, A Direct-to-patient Program in the US

THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab). This follows landmark results demonstrating Repatha significantly…

Read More

Protected: Pre-Treatment LDL-C Calculator

There is no excerpt because this is a protected post.

Read More